.jpg)
Medical Student
Central Michigan University
David Doyle is a third-year medical student at Central Michigan University's College of Medicine, having matriculated in 2020. Originally from Linden, Michigan, he earned a Bachelor of Science in Biology from Palm Beach Atlantic University in 2018. As part of the Frederick M. Supper Honors Program, he completed the Honors Program in Religion, Literature, and Philosophy and was recognized as the Outstanding Student of Arts and Sciences for the university.
Currently, he is also pursuing a doctoral degree in neuroscience, with a primary focus on Huntington's disease and the therapeutic potential of GM1 ganglioside. His research extends into aging, neurodegeneration, and spinal cord injury mechanisms. He is actively involved in investigating herbal-nanoparticle drug delivery systems in a rat stroke model and has contributed to studies on astrocytic activation following ischemic stroke.
Recent Publications Include:
A chapter on prion cell modeling in Prions and Diseases (Springer, 2022).
Research on the financial, legal, and functional challenges of dementia care using digital devices (JMIR Aging, 2023).
A study on astrocytic activation following MCAo ischemic stroke (Neuroglia, 2022).
An analysis of large language models in neuro-oncology (Journal of Neuro-Oncology, 2023).
A bibliometric analysis of AI in medicine, highlighting neurosurgical research trends, presented at the Congress of Neurological Surgeons (2024).
Beyond research, David is engaged in leadership roles, including:
Graduate Assistant at Central Michigan University (since 2022).
Interest Group Leader for the American Association of Neurological Surgeons (AANS) (2022–2023).
Junior Research Director at NERVE (since 2024).